appointments

News

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Anglo-US biotech NodThera has named former Jazz Pharma executive Dan Swisher as its new chief executive, replacing Alan Watt, who will take on the dual roles of president

News

Citi analyst Andrew Baum to head Pfizer strategy team

Pfizer will draw on the expertise of Citi analyst Andrew Baum when it comes to portfolio management and capital deployment, naming him chief strategy and innovation office

News

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

UK start-up George Medicines has named Mark Mallon as its new chief executive, who will oversee the company as it tries to get its triple therapy for high blood pressure o

Sales & Marketing

Changing Faces: Agency, consultancy, and investor hires from...

Another light month in March on the agency and investor side, but there are a few appointments worth noting.

Digital

Changing Faces: Digital and supplier hires from March 2024

We’re back with another hires round-up for digital health companies and pharma suppliers. There was plenty of action across the sector in March.

R&D

Changing Faces: Pharma and biotech hires from March 2024

Once again in March, the pharmaceutical world saw a series of notable hires. From biotech to pharma, companies are strengthening their teams with experienced professionals.

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

Citi analyst Andrew Baum to head Pfizer strategy team

Ex-Ironwood CEO Mark Mallon pops up at George Medicines

Changing Faces: Agency, consultancy, and investor hires from...

Changing Faces: Digital and supplier hires from March 2024

Changing Faces: Pharma and biotech hires from March 2024

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

appointments

Editor's Picks